IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	83.81	73.24	65.56	53.3	41.81
Revenue Growth (YoY)	14.43%	11.71%	23.00%	27.47%	31.84%
Cost of Revenue	19.49	16.89	15.4	12.02	9.76
Gross Profit	64.32	56.35	50.16	41.28	32.05
Selling, General & Admin	35.2	31.55	27.26	23.38	20.33
Research & Development	2.98	2.83	2.86	2.28	1.91
Total Operating Expenses	38.18	34.39	30.12	25.65	22.23
Operating Income	26.15	21.96	20.04	15.63	9.82
Total Non-Operating Income (Expense)	2.21	2.31	1.7	0.55	0.02
Pretax Income	28.36	24.28	21.74	16.18	9.84
Provision for Income Taxes	5.88	5.04	4.55	3.35	0.51
Net Income	22.48	19.23	17.19	12.83	9.33
Net Income to Common	22.48	19.23	17.19	12.83	9.33
Net Income Growth	16.88%	11.87%	34.02%	37.56%	581.19%
Shares Outstanding (Basic)	13	13	13	13	12
Shares Outstanding (Diluted)	13	13	13	13	13
Shares Change (YoY)	0.55%	0.48%	0.69%	0.36%	1.21%
EPS (Basic)	1.77	1.52	1.36	1.02	0.76
EPS (Diluted)	1.75	1.50	1.35	1.02	0.74
EPS Growth	16.67%	11.11%	32.35%	37.84%	572.73%
Free Cash Flow	0	17.62	6.02	9.22	10.78
Free Cash Flow Growth	-	192.46%	-34.66%	-14.44%	100.50%
Free Cash Flow Per Share	-	1.38	0.47	0.73	0.86
Dividends Per Share	0.710	0.470	0.150	-	-
Dividend Growth	51.06%	213.33%	-	-	-
Gross Margin	76.75%	76.94%	76.50%	77.45%	76.65%
Operating Margin	31.20%	29.99%	30.56%	29.32%	23.48%
Profit Margin	26.82%	26.26%	26.22%	24.07%	22.30%
FCF Margin	0.00%	24.06%	9.19%	17.30%	25.77%
EBITDA	26.15	22.78	20.8	16.3	11.22
EBITDA Margin	31.20%	31.11%	31.73%	30.58%	26.84%
EBIT	26.15	21.96	20.04	15.63	9.82
EBIT Margin	31.20%	29.99%	30.56%	29.32%	23.48%
Effective Tax Rate	20.74%	20.77%	20.91%	20.72%	5.19%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q